Dietary characteristics of Mexican patients with irritable bowel syndrome: Is there a distinction from the general population?

Introduction: Irritable bowel syndrome (IBS) is a multifactorial condition, in which diet is a main trigger of symptoms. Many patients modify their diet without professional supervision, which can cause nutritional risks or aggravate symptoms. The aim of this study was to evaluate the dietary intake...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Amieva-Balmori, G.P. Martínez-Pérez, M.R. Francisco, A. Triana-Romero, A.A. Ortiz-Lorenzo, G.A. Hernández-Ramírez, J.A. Martínez-Conejo, G.A. Violante-Hernández, A.D. Cano-Contreras, J.M. Remes-Troche
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Revista de Gastroenterología de México (English Edition)
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2255534X25000416
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Irritable bowel syndrome (IBS) is a multifactorial condition, in which diet is a main trigger of symptoms. Many patients modify their diet without professional supervision, which can cause nutritional risks or aggravate symptoms. The aim of this study was to evaluate the dietary intake of patients with IBS versus healthy subjects. Material and methods: An observational, analytic, cross-sectional study was conducted on 108 subjects: 77 (71.3%) diagnosed with IBS (Rome IV criteria) and 31 (28.7%) healthy controls. Patient age was from 18 to 66 years and the woman-to-man ratio was 4.1:1. Both groups completed a 7-day food diary, registering their usual diet that was then analyzed using a nutrition software program. Results: Macronutrient intake was similar between the two groups but the patients with IBS had a significantly higher intake of vitamins D (p ≤ 0.001), B1 (p ≤ 0.001), B2 (p ≤ 0.001), and B3 (p ≤ 0.001). There was greater vitamin B3 intake in patients with an IBS subtype (p = 0.005). There were no significant differences in fiber consumption. Conclusion: The diet of Mexican patients with IBS was slightly different from that of healthy subjects. The IBS patients consumed more fiber and their FODMAP intake was similar to that of the healthy controls. Even though the majority of the IBS patients met the recommendations for macronutrient and micronutrient intake, nutritional guidance in the management of IBS is recommended because dietary adjustments can significantly improve symptoms. Resumen: Introducción: El síndrome de intestino irritable (SII) es una condición multifactorial, donde la dieta es un desencadenante principal de los síntomas. Muchos pacientes modifican su alimentación sin supervisión profesional, lo que puede ocasionar riesgos nutricionales o agravar los síntomas. El objetivo de este estudio fue evaluar la ingesta dietética de pacientes con SII comparado con sujetos sanos. Material y métodos: Estudio transversal, analítico y observacional con 108 sujetos: 77 (71.3%) con diagnóstico de SII (criterios Roma IV) y 31 (28.7%) controles sanos, con edades entre 18 y 66 años y una proporción de 4.1:1 entre mujeres y hombres. Ambos grupos completaron un diario alimentario de 7 días, registrando su dieta habitual, analizada mediante un programa de nutrición. Resultados: La ingesta de macronutrientes fue similar entre los grupos. Sin embargo, los pacientes con SII mostraron un consumo significativamente mayor de vitaminas D (p ≤ 0.001), B1 (p ≤ 0.001), B2 (p ≤ 0.001) y B3 (p ≤ 0.001). Entre los subtipos de SII, se observó un mayor consumo de vitamina B3 (p = 0.005). No hubo diferencias significativas en el consumo de fibra. Conclusión: La dieta de los pacientes mexicanos con SII presenta leves diferencias respecto a los sujetos sanos. Los pacientes con SII consumen más fibra y tienen una ingesta de FODMAPs similar a los controles sanos. Aunque la mayoría de estos pacientes cumple con la ingesta recomendada de macro y micronutrientes, se recomienda orientación nutricional en el manejo del SII, ya que los ajustes dietéticos pueden mejorar significativamente los síntomas.
ISSN:2255-534X